Literature DB >> 6249758

Aerosol infection of mice with Bordetella pertussis.

Y Sato, K Izumiya, H Sato, J L Cowell, C R Manclark.   

Abstract

Aerosol inhalation of Bordetella pertussis Tohama phase I resulted in a reproducible and uniform infection of mice (strain DDY or ICR). Mice in groups of 10 exposed for 30 min to aerosols generated from bacterial suspensions of 10(9) and 10(10) organisms per ml resulted in mean bacterial counts of 2.3 (+/- 0.3) X 10(4) and 1.0 (+/- 0.3) X 10(5) colony-forming units, respectively, in the lung of each animal. Subsequent studies using a 30-min aerosol inoculation of ICR mice with 2 X 10(9) bacterial cells per ml showed: (i) B. pertussis cells reached a maximum of about 10(7) colony-forming units per lung 14 days after inhalation. (ii) Deaths (10 to 100%, depending on mouse age) occurred 10 to 14 days after exposure. (iii) The lung weight and the leukocyte count increased from basal values of 100 mg and 10(4) leukocytes per mm3 to a plateau of 950 mg and 1.95 X 10(5) leukocytes per mm3, respectively, 14 days after challenge. (iv) There was a significantly reduced rate of body weight gain by infected mice compared to noninfected mice. (v) With mortality as the criterion for disease, susceptibility varied with the age of mice as follows: 10 days old greater than 18 greater than 28 greater than 49. (vi) Bacteria were associated with ciliated respiratory epithelial cells by scanning electron microscopy.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6249758      PMCID: PMC551104          DOI: 10.1128/iai.29.1.261-266.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Lymphocyte subpopulations in pertussis.

Authors:  I Tsukimoto; B C Lampkin
Journal:  J Pediatr       Date:  1976-05       Impact factor: 4.406

2.  The white blood cell count and the erythrocyte sedimentation rate in pertussis.

Authors:  J LAGERGREN
Journal:  Acta Paediatr       Date:  1963-07       Impact factor: 2.299

3.  The intranasal infection of mice with Bordetella pertussis.

Authors:  J M DOLBY; D C THOW; A F STANDFAST
Journal:  J Hyg (Lond)       Date:  1961-06

4.  Some factors influencing the virulence for mice of Bordetella pertussis by the intracerebral route.

Authors:  A F STANDFAST
Journal:  Immunology       Date:  1958-04       Impact factor: 7.397

5.  A comparison of passive protection tests against intranasal and intracerebral challenges with Bordetella pertussis.

Authors:  J M DOLBY; A F STANDFAST
Journal:  Immunology       Date:  1958-04       Impact factor: 7.397

6.  Some observations made during experiments on mice inoculated with H. pertussis.

Authors:  E K ANDERSEN
Journal:  Acta Pathol Microbiol Scand       Date:  1952

7.  Scanning electron microscopic study of hamster tracheal organ cultures infected with Bordetella pertussis.

Authors:  K E Muse; A M Collier; J B Baseman
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

8.  The effect of LPF (leukocytosis promoting factor) on the kinetics of colony forming cells.

Authors:  M Seki; Y Sato
Journal:  Acta Pathol Jpn       Date:  1973-02

9.  Experimental pertussis infection in the marmoset: type specificity of active immunity.

Authors:  T N Stanbridge; N W Preston
Journal:  J Hyg (Lond)       Date:  1974-04

10.  Isolation and properties of the leukocytosis- and lymphocytosis-promoting factor of Bordetella pertussis.

Authors:  S I Morse; J H Morse
Journal:  J Exp Med       Date:  1976-06-01       Impact factor: 14.307

View more
  37 in total

1.  Proliferative responses and gamma interferon and tumor necrosis factor production by lymphocytes isolated from tracheobroncheal lymph nodes and spleen of mice aerosol infected with Bordetella pertussis.

Authors:  J W Petersen; P H Ibsen; K Hasløv; I Heron
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

2.  Characterization of vir-activated TnphoA gene fusions in Bordetella pertussis.

Authors:  T M Finn; R Shahin; J J Mekalanos
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

3.  Protective effects of pertussis immunoglobulin (P-IGIV) in the aerosol challenge model.

Authors:  J B Bruss; G R Siber
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

4.  Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0.

Authors:  A Barnard; B P Mahon; J Watkins; K Redhead; K H Mills
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

5.  Pertussis toxin analog with reduced enzymatic and biological activities is a protective immunogen.

Authors:  A Kimura; K T Mountzouros; P A Schad; W Cieplak; J L Cowell
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

6.  Mucosal immunization with filamentous hemagglutinin protects against Bordetella pertussis respiratory infection.

Authors:  R D Shahin; D F Amsbaugh; M F Leef
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

7.  In vitro inhibition of murine macrophage migration by Bordetella pertussis lymphocytosis-promoting factor.

Authors:  B D Meade; P D Kind; J B Ewell; P P McGrath; C R Manclark
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

8.  Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity.

Authors:  K Redhead; J Watkins; A Barnard; K H Mills
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

9.  Pertussis toxin inhibits early chemokine production to delay neutrophil recruitment in response to Bordetella pertussis respiratory tract infection in mice.

Authors:  Charlotte Andreasen; Nicholas H Carbonetti
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

10.  Adjuvanticity and protective immunity elicited by Bordetella pertussis antigens encapsulated in poly(DL-lactide-co-glycolide) microspheres.

Authors:  R Shahin; M Leef; J Eldridge; M Hudson; R Gilley
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.